期刊文献+

同源盒基因A13转染对肾小管上皮细胞间充质转化和骨形成蛋白7表达的影响 被引量:1

Effect of Homeobox A13 transfection on epithelial-mesenchymal transition and bone morphogenetic protein-7 expression in kidney tubular epithelial cells
原文传递
导出
摘要 目的探讨转染同源盒基因A13(HOXA13)对人血清白蛋白(HSA)诱导的人肾小管上皮细胞(HKC)间充质转化(EMT)和骨形成蛋白7(BMP-7)表达的影响。方法体外培养的HKC细胞株经人血清白蛋白(20 mg/m L)作用48 h后,采用免疫印迹法检测HKC细胞角蛋白(CK)、波形蛋白(vimentin)和HOXA13蛋白的表达。应用脂质体转染技术上调HKC细胞HOXA13表达,观察HOXA13不同表达水平对人血清白蛋白超载诱导CK、vimentin、BMP-7表达改变的影响。结果 20 mg/m L HSA刺激HKC细胞48 h后,HKC细胞出现EMT样改变:CK表达下降(P<0.01)、vimentin表达增高(P<0.01);HSA超载同时使HKC细胞内HOXA13、BMP-7表达下降。HOXA13转染上调HKC细胞内HOXA13表达后,显著抑制了HSA超载诱导的EMT发生(P<0.05)和BMP-7表达的下降(P<0.05)。结论转染HOXA13可拮抗白蛋白超载诱导HKC细胞发生EMT的作用,这种作用可能与HOXA13上调BMP-7表达有关。 Objective To examine the transfection of Homeobox A13(HOXA13) on epithelial-mesenchymal transition(EMT) and the expression of bone morphogenetic protein-7(BMP-7) induced by albumin-overload in human kidney tubular epithelial cells(HKCs). Methods The cultured HKCs were treated with 20 mg/m L human serum albumin(HSA) for 48 hours. Protein expression of cytokeratin(CK), vimentin and HOXA13 in the HKCs was assessed by Western blot. Protein expression of CK, vimentin, and BMP-7 was also detected in HKCs transfected with lipofectamine contained HOXA13 DNA. Results HSA induced EMT in HKCs, presented by decreased CK expression(P〈0.01) and increased vimentin expression(P〈0.01). The up-regulated expression of HOXA13 transfected by lipofectamine inhibited the level of EMT induced by HSA in HKCs(P〈0.05). The decreased rate of BMP-7 protein expression induced by HSA was inhibited by over-expressed HOXA13 in HKCs(P〈0.05). Conclusions Transfection of HOXA13 in HKCs could inhibit the degree of EMT induced by albumin-overload, possibly by increasing BMP-7 expression.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2015年第12期1342-1347,共6页 Chinese Journal of Contemporary Pediatrics
基金 中南大学湘雅名医科研基金
关键词 白蛋白超载 上皮细胞-间充质转化 同源盒基因A13 骨形成蛋白-7 肾小管上皮细胞 Albumin overload Epithelial-mesenchymal transition HOXA13 Bone morphogenetic protein-7 Kidney tubular epithelial cell
  • 相关文献

参考文献15

  • 1Eddy AA. Overview of the cellular and molecular basis of kidney fibrosis[J]. Kidney Int $uppl (2011), 2014, 4(1): 2-8.
  • 2Prunotto M, Budd DC, Gabbiani G, et al. Epithelial- mesenehymal crosstalk alteration in kidney fibrosis[J]. J Pathol, 2012, 228(2): 131-147.
  • 3Wang Z, Zhao J, Zhang J, et al. Protective effect of BMP-7 against aristolochic acid-induced renal tubular epithelial cell injury[J]. Toxicol Lett, 2010, 198(3): 348-357.
  • 4Quinonez SC, Innis JW. Human HOX gene disorders[J]. Mol Genet Metal), 2014, 111(1): 4-15.
  • 5Wellik DM. HOX genes and kidney development[J]. Pediatr Nephrol, 2011, 26(9): 1559-1565.
  • 6Parker L, Mangwani J, Wakeling E, et al. Hallux valgus interphalangeus and a novel mutation in HOXA13. Part of the broadening spectrum of Hand-Foot-Genital syndrome[J]. Foot Ankle Surg, 2011, 17(2): e28-e30.
  • 7Hamasaki Y, Doi K, Okamoto K, et al. 3-Hydroxy-3- methylglutaryl-coenzyme A reductase inhibitor simvastatin ameliorates renal fibrosis through HOXA13-USAG-1 pathway[J]. Lab Invest, 2012, 92(8): 1161-1170.
  • 8Williams TM, Williams ME, Heaton JH, et al. Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability[J]. Nucleic Acids Res, 2005, 33(14): 4475-4484.
  • 9Ibrini J, Fadel S, Chana RS, et al. Albumin-induced epithelial mesenchymal transformation[J]. Nephron Exp Nephrol, 2012, 120(3): e91-e102.
  • 10姜莹,李晓燕,何庆南,谭爱斌,周频,易著文.白蛋白超载对人肾小管上皮细胞EMT及激素耐药相关因素的影响[J].中国现代医学杂志,2010,20(21):3299-3302. 被引量:3

二级参考文献29

  • 1何小解,易著文,党西强,张慧琼,何庆南,莫双红,白海涛,耿文茂,杨华彬.GRβ在原发性肾病综合征患儿糖皮质激素耐药中的作用[J].中华儿科杂志,2005,43(2):109-112. 被引量:22
  • 2FILLER G, YOUNG E, GEIER P, et al. Is there really an increase in non-minimal change nephrotic syndrome in children[J]. Am J Kidney Dis, 2003, 42(6): 1107-1113.
  • 3ABBATE M, ZOJA C, REMUZZI G. How does proteinuria cause progressive renal damage [J]. J Am Soc Nephrol, 2006, 17(11): 2974-2984.
  • 4HAY ED, ZU KA. Transformation between epithelium and mesenchyme: normal pathological, and experimentally induced [J]. Am J kidney Dis, 1995, 26: 678-690.
  • 5HAACK D, SCHARER K, ASAM-TAUSCHER A, et al. Glueocorticoid receptors in idiopathic nephrotic syndrome [J]. Pediatr Nephrol, 1999, 13(8): 653-656.
  • 6WASILEWSKA A, ZOCH-ZWIERZ W, PIETRUCZUK M. Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor[J]. Eur J Pediatr, 2007, 166(5): 447-452.
  • 7DIXON R, BRUNSKILL NJ. Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: implications for the pathophysiology of proteinuric slates [J]. J Am Soe Nephrol, 1999, 10(7): 1487-1497.
  • 8OSHIMA RG. Intermediate f'daments: a historical perspective[J]. Exp Cell Res, 2007, 313(10): 1981-1994.
  • 9SKINNIDER BF, FOLPE AL, HENNIGAR RA, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a eytokeratin antibody panel in the differential diagnosis of renal tumors [J]. Am J Surg Pathal, 2005, 29(6): 747-754.
  • 10LANG SH, HYDE C, REID IN, et al. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma [J]. Prostate, 2002, 52 (4): 253-263.

共引文献16

同被引文献3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部